This article is more than 5 years old. Information may no longer be current.

Compliance rates reduced for patients on three glaucoma drugs

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK – Compliance rates for glaucoma treatment drop off significantly when the patient is prescribed three concomitant drugs, according to a recent study discussed at the PRIMARY CARE OPTOMETRY NEWS symposium here.

Presenter J. James Thimons, OD, cited the study, which found that on a treatment regimen of one drug, 82% of patients were found to be in compliance. This number was reduced to 71% for patients on two drugs and only 50% compliance for patients on one drug.

“We might ask ‘at what number of drugs would you start to explore surgical options?’” Dr. Thimons said. “I would say that number is three drugs.”